Edges in Network
Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | MEF2D |
Upstream (Parents) |
---|
(<<) ADAM9 → MEF2D |
(<<) BCL3 → MEF2D |
(<<) CABC1 → MEF2D |
(<<) CHSY1 → MEF2D |
(<<) GNAQ → MEF2D |
(<<) GNG10 → MEF2D |
(<<) GRIN1 → MEF2D |
(<<) GRK6 → MEF2D |
(<<) GRPEL1 → MEF2D |
(<<) HIF1A → MEF2D |
(<<) HPS6 → MEF2D |
(<<) HYAL1 → MEF2D |
(<<) JUND → MEF2D |
(<<) KLF10 → MEF2D |
(<<) MAP3K7 → MEF2D |
(<<) MCL1 → MEF2D |
(<<) NCOR2 → MEF2D |
(<<) NRN1 → MEF2D |
(<<) NUDT6 → MEF2D |
(<<) PPP1CA → MEF2D |
(<<) PPP3CA → MEF2D |
(<<) PPRC1 → MEF2D |
(<<) PRDX6 → MEF2D |
(<<) PRKCD → MEF2D |
(<<) PRNP → MEF2D |
(<<) RAC1 → MEF2D |
(<<) RHOA → MEF2D |
(<<) RHOD → MEF2D |
(<<) RND3 → MEF2D |
(<<) RNF11 → MEF2D |
(<<) SF3A2 → MEF2D |
(<<) SHC1 → MEF2D |
(<<) SMURF2 → MEF2D |
(<<) SPRY2 → MEF2D |
(<<) VCP → MEF2D |
(<<) VPS28 → MEF2D |
(<<) YWHAQ → MEF2D |
(<<) ZNF215 → MEF2D |
Downstream (Children) |
---|
MEF2D → ABLIM1 (>>) |
MEF2D → B3GNT2 (>>) |
MEF2D → CEACAM1 (>>) |
MEF2D → HK2 (>>) |
MEF2D → HOPX (>>) |
MEF2D → IL1A (>>) |
MEF2D → MAPK7 (>>) |
MEF2D → ME1 (>>) |
MEF2D → NRSN2 (>>) |
MEF2D → PRKCG (>>) |
MEF2D → RPS12 (>>) |
MEF2D → SGCA (>>) |
MEF2D → SMO (>>) |
MEF2D → SPATA2L (>>) |
MEF2D → TCEB1 (>>) |